164 related articles for article (PubMed ID: 38263362)
1. The m
Yang Z; Zhang S; Xiong J; Xia T; Zhu R; Miao M; Li K; Chen W; Zhang L; You Y; You B
Cell Death Discov; 2024 Jan; 10(1):43. PubMed ID: 38263362
[TBL] [Abstract][Full Text] [Related]
2. A study of RNA m6A demethylases in oral epithelial dysplasia and oral squamous cell carcinoma.
Udompatanakorn C; Sriviriyakul P; Taebunpakul P
J Oral Biol Craniofac Res; 2023; 13(2):111-116. PubMed ID: 36582218
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
4. RNA-Seq data of ALKBH5 and FTO double knockout HEK293T human cells.
Smolin EA; Buyan AI; Lyabin DN; Kulakovskiy IV; Eliseeva IA
Data Brief; 2022 Jun; 42():108187. PubMed ID: 35516002
[TBL] [Abstract][Full Text] [Related]
5. The N
Strick A; von Hagen F; Gundert L; Klümper N; Tolkach Y; Schmidt D; Kristiansen G; Toma M; Ritter M; Ellinger J
BJU Int; 2020 Apr; 125(4):617-624. PubMed ID: 31985880
[TBL] [Abstract][Full Text] [Related]
6. N
Xu K; Mo Y; Li D; Yu Q; Wang L; Lin F; Kong C; Balelang MF; Zhang A; Chen S; Dai Q; Wang J
Ther Adv Chronic Dis; 2020; 11():2040622320916024. PubMed ID: 32426101
[TBL] [Abstract][Full Text] [Related]
7. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
8. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes.
Guimarães-Teixeira C; Barros-Silva D; Lobo J; Soares-Fernandes D; Constâncio V; Leite-Silva P; Silva-Santos R; Braga I; Henrique R; Miranda-Gonçalves V; Jerónimo C
J Pers Med; 2021 Sep; 11(10):. PubMed ID: 34683137
[TBL] [Abstract][Full Text] [Related]
10. Depletion of the m
Hu W; Klümper N; Schmidt D; Ritter M; Ellinger J; Hauser S
Am J Transl Res; 2023; 15(3):1744-1755. PubMed ID: 37056835
[TBL] [Abstract][Full Text] [Related]
11. m
Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
[TBL] [Abstract][Full Text] [Related]
12. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.
Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C
Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126
[TBL] [Abstract][Full Text] [Related]
13. Distinct RNA
Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
[TBL] [Abstract][Full Text] [Related]
14. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
15. Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis.
Zhang TP; Li R; Wang LJ; Li HM
Front Cell Infect Microbiol; 2022; 12():1074380. PubMed ID: 36619747
[TBL] [Abstract][Full Text] [Related]
16. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
17. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
19. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
Shen F; Huang W; Huang JT; Xiong J; Yang Y; Wu K; Jia GF; Chen J; Feng YQ; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2015 Jan; 100(1):E148-54. PubMed ID: 25303482
[TBL] [Abstract][Full Text] [Related]
20. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
